Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2022
∙
NACI
NACI Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
2022
∙
NACI
NACI Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
2022
∙
Shannon Stokley
National and state-level HPV vaccination coverage
2022
∙
NIAC
NIAC recommendations for COVID-19 booster vaccination of those aged 12- 15 years
2022
∙
NIAC
NIAC Recommendations for Monkeypox Vaccination
2022
∙
NIAC
NIAC Updated recommendation for HPV vaccination
2022
NITAG-BF advice on the introduction of anti-typhoid conjugate vaccines in the expanded programme on immunization
2022
NITAG-BF recommendation on the introduction of SINOVAC in Burkina Faso
2022
∙
Lauri Markowitz
One-Dose Human Papillomavirus (HPV) Vaccination: Overview of Current Evidence
2022
∙
ACIP, Kevin Chatham-Stephens
Pediatric COVID-19 Vaccine Planning for Children 6 Months–4 Years
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register